#藥物研發

Eli Lilly’s New Oral GLP-1 Drug 'Foundayo' Receives FDA Approval

The FDA has approved Eli Lilly’s once-daily oral weight-loss drug, Foundayo. This new oral option is set to challenge existing injectable therapies and could significantly improve long-term treatment adherence for obesity patients.

Williams·Apr 2, 2026·2 min read